TRT Bloodwork: The Labs That Get Monitored and Why

TRT bloodwork is the backbone of safe testosterone replacement therapy: a set of labs, most importantly total and free testosterone, estradiol, hematocrit, PSA, and lipids, that confirm the diagnosis, guide dosing, and catch the main risks early. Reading them is your clinician's job, not yours; the values below are general reference categories, not targets to self-manage to. TRT is a prescription medical therapy (testosterone is a Schedule III controlled substance) that requires both a diagnosis and ongoing lab monitoring by a licensed clinician, and this is education, not medical advice.

Why labs, not feelings, drive TRT

It is tempting to judge TRT by how you feel, but symptom relief alone is a poor steering wheel. Testosterone affects red blood cell production, estrogen levels, lipids, and prostate markers, and several of those can drift in a risky direction while you still feel fine. That is the whole reason TRT is built around bloodwork: the labs see things symptoms cannot.

Labs also do the upstream job of confirming you need treatment at all. The diagnosis of hypogonadism requires both symptoms and confirmed low testosterone, which is why a careful provider repeats the testosterone measurement rather than acting on a single number. Our signs of low testosterone article covers why a checklist of symptoms is not enough on its own.

Baseline labs: before the first dose

Baseline bloodwork does two things at once: it confirms the diagnosis and it sets the reference point that every future result is measured against. A typical baseline panel a clinician orders includes:

• Total testosterone, drawn in the morning (commonly between 7 and 11 AM) in the fasting state, and usually confirmed on a second occasion. The Endocrine Society defines low total testosterone as below about 264 ng/dL, but a single low value is not sufficient to diagnose hypogonadism.
• Free testosterone, the biologically active fraction, when total testosterone is borderline or when SHBG (the protein that binds testosterone) is abnormal. We unpack that distinction in free versus total testosterone.
• LH and FSH, to distinguish primary hypogonadism (the testes) from secondary (the signaling above them), which shapes treatment choices.
• Estradiol, ideally a sensitive assay rather than a standard immunoassay.
• Hematocrit and a complete blood count (CBC).
• PSA, when age (roughly 40 and up) or clinical context calls for it.
• Lipid panel, metabolic panel, and liver enzymes, for general safety baselines.

Skipping the baseline is a mistake, because without it later results have nothing meaningful to be compared against.

The key markers and what each one watches

The panel below summarizes the core markers a clinician monitors on TRT, what each reveals, and a typical cadence. The cadence is general reference; your provider individualizes it. None of these are values to interpret or act on yourself.

Lab	What it reveals	Typical monitoring cadence
Total testosterone	Overall testosterone level; the primary response marker	Baseline, ~6 to 8 weeks, then every 3 to 6 months in year one, then annually
Free testosterone	The biologically active fraction; useful when total is borderline or SHBG is off	As needed alongside total testosterone
Estradiol (sensitive assay)	Estrogen converted from testosterone; both high and low cause problems	Baseline and periodically, read against symptoms
Hematocrit / CBC	Red blood cell fraction; the main thrombosis-risk marker	Baseline, 3, 6, 12 months, then annually
PSA	Prostate marker; watches for unmasking subclinical disease	Baseline and periodically for men ~40 and older
Lipids / metabolic / liver	General cardiovascular and metabolic safety	Baseline and periodically

A few of these deserve a closer look.

Testosterone: the response marker

Total testosterone is the headline number, but it is not chased to a rigid target. Many clinicians aim for symptomatic improvement somewhere in the mid-normal range, often discussed around 400 to 700 ng/dL, while the Endocrine Society notably does not specify a single fixed target and instead emphasizes symptom relief within the normal range. Free testosterone earns its place when total testosterone is borderline and SHBG is skewing the picture, because it reflects the testosterone actually available to tissues.

Estradiol: a balance, not a ceiling

Testosterone aromatizes (converts) to estradiol, and estradiol is not the enemy. Both extremes cause trouble. Elevated estradiol can drive water retention, mood changes, and breast tissue changes (gynecomastia), while over-suppressed estradiol causes joint pain, low libido, and mood problems. That is why a sensitive assay is used and why your clinician reads it against your symptoms rather than treating any single value as a problem to crush.

Hematocrit: the risk to respect

Testosterone stimulates red blood cell production, so hematocrit commonly rises on TRT, and an elevated hematocrit thickens the blood and raises clotting risk. This is the single most important safety lab on TRT, which is why it has its own monitoring rhythm and its own dedicated article: see hematocrit on TRT for the full picture, including how it is managed.

PSA: unmasking, not causing

The evidence does not support the idea that TRT causes prostate cancer, but testosterone can theoretically accelerate or unmask a pre-existing subclinical prostate condition. Monitoring PSA before and during therapy lets a clinician catch a meaningful change early. The decision to monitor and how to interpret a change both belong to your provider.

How often labs are checked

Monitoring is front-loaded into the first year, when your provider is still finding the right dose and watching how your body responds. A common pattern, individualized by your clinician, runs: baseline, a recheck around six to eight weeks after starting, then every three to six months for the rest of the first year, and at least annually once you are stable. Hematocrit is frequently checked at three, six, and twelve months and then yearly.

The recurring theme is the trend. A single lab is a snapshot influenced by timing, hydration, and recent dosing, while a trend over multiple draws is the real signal. A testosterone level also depends heavily on when it was drawn relative to your last injection, which is exactly why consistent timing and a clear record matter.

Why draw timing changes everything

This point is worth its own section, because it trips up more people than any other part of TRT labs. With injectable testosterone, your blood level rises after a dose and falls before the next one, so the same person can produce very different testosterone numbers depending on when blood is drawn relative to the last shot.

A draw taken the day after an injection captures something closer to a peak, while a draw taken right before the next dose captures a trough. Neither is wrong, but they answer different questions, and comparing a peak from one visit to a trough from another is comparing apples to oranges. That is why clinicians often standardize the draw, frequently asking for a trough measurement just before the next dose, so results are comparable visit to visit. The practical implication for you is simple: keep the timing consistent, and make sure your provider knows when your last dose was, because a number without that context can be misread.

The other markers worth knowing

Beyond the headline labs, a few additional values often appear and are worth understanding at a glance.

SHBG (sex hormone-binding globulin) is the protein that binds much of your testosterone in the blood. When SHBG is high, more of your testosterone is bound and unavailable, so total testosterone can look adequate while the usable free fraction is low; when SHBG is low, the opposite. That is why SHBG helps explain a mismatch between how someone feels and what their total testosterone says, and why free versus total testosterone is a distinction worth understanding.

Metabolic and liver panels provide general safety context, checking blood sugar, kidney function, and liver enzymes, since hormonal therapy sits within your overall health rather than apart from it. Lipids matter because testosterone can influence cholesterol fractions, so a clinician watches the lipid trend over time as part of cardiovascular safety.

None of these are values to interpret yourself. They are pieces a clinician assembles into a complete picture, and the value of having them in one place is that the picture is easier to see.

Labs confirm the diagnosis, not just the dose

It is easy to think of TRT labs as purely a dosing tool, but their first job is diagnostic, and that job is non-negotiable. Hypogonadism is diagnosed from both symptoms and confirmed low testosterone, which is why a careful clinician repeats the morning testosterone measurement rather than starting therapy off a single low value. Symptoms like fatigue and low libido have many causes, and treating a number that was never truly low, or was low only on one off day, is how people end up on a therapy they did not need.

This is also why a provider checks LH and FSH at baseline: those values, read together with testosterone, separate primary from secondary hypogonadism and shape what treatment even makes sense. The bloodwork, in other words, is doing two jobs at once, confirming that treatment is warranted and establishing the baseline that every future result is judged against. Skipping or rushing it undermines everything that follows.

What to ask a provider

Useful questions for a clinician include: Which labs will we run, and how often, given my age and risk factors? What time relative to my dose should I get drawn so the numbers are comparable? How will you decide whether to adjust my dose based on these results? And what would prompt you to act on hematocrit, estradiol, or PSA? A provider experienced in hormonal health answers these against your specific picture.

The tracking angle

A year of TRT generates a stack of lab slips that is hard to read as a story. Myo stores each panel and trends every marker, testosterone, estradiol, hematocrit, PSA, and more, over time, so what would otherwise be scattered PDFs becomes one chart you can hand your prescriber. Because a testosterone result depends on draw timing relative to your dose, Myo keeps labs next to your injection log so the context is never lost, the same way it pairs body-composition data when you log a DEXA scan. Myo organizes a provider-directed protocol and never interprets your labs, recommends a dose, or prescribes.

References

• Endocrine Society. Testosterone Therapy in Men With Hypogonadism: Clinical Practice Guideline. endocrine.org.
• US FDA. Testosterone prescribing information and monitoring guidance. accessdata.fda.gov.
• American Society of Hematology, Blood Advances. Drug-induced erythrocytosis review, 2025, on hematocrit monitoring.
• Endocrine Society Hypogonadism patient library on diagnosis requiring symptoms plus confirmed low testosterone.